FDA applicant
Atraverse Medical
FDA records 4 decisions for Atraverse Medical (Cardiff By The Sea, CA) from 2024 to 2026: 4 510(k) clearances. Most are in product codes DXF (Catheter, Septostomy) and GEI (Electrosurgical, Cutting & Coagulation &…). Since 2016 its 510(k)s took a median of 30 days from receipt to decision, against 83 for FDA’s reviews in the same codes and years. Its devices cite 4 predicates, 2 of them its own earlier devices. No recall is linked to its devices.
FDA’s records also spell it “Atraverse Medical, Inc.”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Atraverse Medical’s devices, and how often a recall has named them.
FDA decisions per year
2in 2025
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2024.
Planning a device like Atraverse Medical’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report